Victory Capital Management Inc. Has $1.16 Million Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Victory Capital Management Inc. lowered its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 65.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 124,688 shares of the pharmacy operator's stock after selling 239,977 shares during the quarter. Victory Capital Management Inc.'s holdings in Walgreens Boots Alliance were worth $1,163,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in WBA. First Financial Corp IN grew its holdings in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after purchasing an additional 885 shares in the last quarter. Golden State Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $26,000. Riverview Trust Co grew its holdings in shares of Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,590 shares in the last quarter. Venturi Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $28,000. Finally, TD Private Client Wealth LLC lifted its position in shares of Walgreens Boots Alliance by 8,670.3% during the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock worth $29,000 after buying an additional 3,208 shares during the period. Institutional investors and hedge funds own 58.59% of the company's stock.

Remove Ads

Walgreens Boots Alliance Trading Down 0.2 %

Shares of NASDAQ WBA traded down $0.02 during midday trading on Friday, hitting $11.10. The stock had a trading volume of 37,249,707 shares, compared to its average volume of 20,812,172. The company's 50-day simple moving average is $10.96 and its 200 day simple moving average is $9.83. The firm has a market cap of $9.59 billion, a P/E ratio of -1.08, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.05. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to analysts' expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business's revenue for the quarter was up 7.6% on a year-over-year basis. During the same period last year, the firm earned $0.66 EPS. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. StockNews.com assumed coverage on Walgreens Boots Alliance in a research report on Tuesday, March 18th. They set a "hold" rating for the company. Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Bank of America raised their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research report on Monday, January 13th. Truist Financial cut their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research report on Friday, January 31st. Finally, Evercore ISI raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.